Drug Report History #2471
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2017-04-06 | Was: 2017-03-14 |
| Drug Identification Number (Changed) | Updated to: 02373130 | Was: 00001686 |
| Brand name (Changed) | Updated to: XYLOCAINE 2% WITH EPINEPHRINE 1:200000 | Was: XYLOCAINE VISCOUS 2% |
| Common or Proper name (Changed) | Updated to: Lidocaine Hydrochloride and Epinephrine Bitartrate Injection | Was: lidocaine hydrochloride solution |
| Company Name | ASPEN PHARMACARE CANADA INC. | ASPEN PHARMACARE CANADA INC. |
| Ingredients (Changed) | Updated to: LIDOCAINE HYDROCHLORIDE EPINEPHRINE RACEMIC | Was: LIDOCAINE HYDROCHLORIDE |
| Strength(s) (Changed) | Updated to: 20MG 0.005MG | Was: 20MG |
| Dosage form(s) (Changed) | Updated to: SOLUTION | Was: LIQUID |
| Route of administration (Changed) | Updated to: BLOCK/INFILTRATION | Was: ORAL TOPICAL |
| Packaging size (Changed) | Updated to: 20 mL | Was: 100 mL |
| Additional packaging sizes | ||
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage (Changed) | Updated to: Delay in shipping of the drug. | Was: Shortage of an inactive ingredient or component. |
| Anticipated start date (Changed) | Updated to: | Was: 2017-03-14 |
| Actual start date (Changed) | Updated to: 2017-04-05 | Was: |
| Estimated end date (Changed) | Updated to: 2017-04-21 | Was: Unknown |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |